Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease.

Sheehan JP, Swerdlow RH, Parker WD, Miller SW, Davis RE, Tuttle JB.

J Neurochem. 1997 Mar;68(3):1221-33.

2.

Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease.

Sheehan JP, Swerdlow RH, Miller SW, Davis RE, Parks JK, Parker WD, Tuttle JB.

J Neurosci. 1997 Jun 15;17(12):4612-22.

3.

Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?

Hartmann A, Michel PP, Troadec JD, Mouatt-Prigent A, Faucheux BA, Ruberg M, Agid Y, Hirsch EC.

J Neurochem. 2001 Mar;76(6):1785-93.

4.

Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease.

Arduíno DM, Esteves AR, Cardoso SM, Oliveira CR.

Neurochem Int. 2009 Sep;55(5):341-8. doi: 10.1016/j.neuint.2009.04.004. Epub 2009 Apr 16.

PMID:
19375464
5.

Characterization of cybrid cell lines containing mtDNA from Huntington's disease patients.

Swerdlow RH, Parks JK, Cassarino DS, Shilling AT, Bennett JP Jr, Harrison MB, Parker WD Jr.

Biochem Biophys Res Commun. 1999 Aug 11;261(3):701-4.

PMID:
10441489
6.

The role of mitochondria in the regulation of calcium influx into Jurkat cells.

Makowska A, Zablocki K, Duszyński J.

Eur J Biochem. 2000 Feb;267(3):877-84.

8.

Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines.

Trimmer PA, Swerdlow RH, Parks JK, Keeney P, Bennett JP Jr, Miller SW, Davis RE, Parker WD Jr.

Exp Neurol. 2000 Mar;162(1):37-50.

PMID:
10716887
10.

Mechanisms of altered Ca2+ signalling in transformed lymphoblastoid cells from patients with bipolar disorder.

Kato T, Ishiwata M, Mori K, Washizuka S, Tajima O, Akiyama T, Kato N.

Int J Neuropsychopharmacol. 2003 Dec;6(4):379-89.

PMID:
14604453
11.

The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease.

Esteves AR, Gozes I, Cardoso SM.

Biochim Biophys Acta. 2014 Jan;1842(1):7-21. doi: 10.1016/j.bbadis.2013.10.003. Epub 2013 Oct 11.

12.

Quantitative study of mitochondrial complex I in platelets of parkinsonian patients.

Blandini F, Nappi G, Greenamyre JT.

Mov Disord. 1998 Jan;13(1):11-5.

PMID:
9452319
13.

Mitochondrial calcium response in human transformed lymphoblastoid cells.

Kato T, Ishiwata M, Nagai T.

Life Sci. 2002 Jun 21;71(5):581-90.

PMID:
12052442
14.

Origin and functional consequences of the complex I defect in Parkinson's disease.

Swerdlow RH, Parks JK, Miller SW, Tuttle JB, Trimmer PA, Sheehan JP, Bennett JP Jr, Davis RE, Parker WD Jr.

Ann Neurol. 1996 Oct;40(4):663-71.

PMID:
8871587
15.

Agonist-evoked mitochondrial Ca2+ signals in mouse pancreatic acinar cells.

González A, Schulz I, Schmid A.

J Biol Chem. 2000 Dec 8;275(49):38680-6.

16.
17.
18.
19.

Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+) -induced cellular model of Parkinson's disease.

Cai X, Jia H, Liu Z, Hou B, Luo C, Feng Z, Li W, Liu J.

J Neurosci Res. 2008 Dec;86(16):3622-34. doi: 10.1002/jnr.21805.

PMID:
18709653
20.

Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease.

Ghosh SS, Swerdlow RH, Miller SW, Sheeman B, Parker WD Jr, Davis RE.

Ann N Y Acad Sci. 1999;893:176-91. Review.

PMID:
10672237
Items per page

Supplemental Content

Write to the Help Desk